CellCarta
Dirk Hendriks is the founder of HistoGeneX N.V., where the focus has been on the development of predictive biomarkers in oncology since 2001. Additionally, Dirk Hendriks has served as a professor and head of the Laboratory of Medical Biochemistry in the Department of Pharmaceutical Sciences at the University of Antwerp since 1985. Dirk Hendriks holds a PhD in clinical pathology with a specialization in fibrinolysis, as well as a PharmD and a second PhD in Pharmaceutical Sciences and Clinical Pathology, all obtained from the University of Antwerp.
This person is not in any offices
CellCarta
CellCarta's Mission is centered on collaborating and partnering with pharmaceutical and biotech companies through proteomics and immune monitoring enabling the acceleration of precision medicine in drug development.With a vision and deep understanding of the needs for complex immune monitoring in novel drug development, Caprion integratedImmuneCarta (formerly known as National Immune Monitoring), with its established and proven proteomics service, ProteoCarta. Together, Caprion now offers a fully integrated and unique service offering to its partners.